Dr. Christopher Naresh Singh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8562 Holly Rd, Grand Blanc, MI 48439 Phone: 810-487-4500 |
Ankur Mehta, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8562 Holly Rd, Grand Blanc, MI 48439 Phone: 810-487-4500 Fax: 810-991-8228 |
Dr. Charles T Zenzen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2240 E Hill Rd, Grand Blanc, MI 48439 Phone: 810-579-0202 Fax: 810-579-0204 |
Dr. Raafay Sophie, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9400 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-487-4500 |
Manjool M Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3181 East Grand Blanc Rd, Grand Blanc, MI 48439 Phone: 810-694-6933 |
Christopher F Herzog, D.O. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9463 Holly Rd, Suite 101, Grand Blanc, MI 48439 Phone: 810-603-2020 Fax: 810-603-2042 |
Amy Duoxi Zhang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3181 East Grand Blanc Rd, Grand Blanc, MI 48439 Phone: 810-694-6933 |
News Archive
The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.
Sexually transmitted diseases are steadily rising in the UK despite a concerted effort on the part of the government to tackle them.
Primary care providers who engaged in an online game to solve clinical cases about hypertension management improved blood pressure control of their patients in a shorter amount of time compared to non-gamers, according to a new study by researchers at Brigham and Women's Hospital (BWH) and the Veterans Affairs Boston Healthcare System.
Teva Pharmaceutical Industries Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS).
› Verified 7 days ago